CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success? - Wikidata - wikimedia - TriplyDB

CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?

CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?

http://www.wikidata.org/entity/Q37692502

about

The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects.Ex vivo and in vivo genome editing: a regulatory scientific framework from early development to clinical implementation.

P2860

Q39386163-385D0072-F46B-46A6-B29A-0542B9C7A7D6 Q47161696-3E1B7ACD-7FF7-42F3-9170-4B1634B32CB7 Q48529117-9A8F8DBE-2D03-4B60-943D-372F1644CE82

P2860

CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?

http://www.wikidata.org/entity/Q37692502

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CRISPR-targeted genome editing ...... s: a path to clinical success?

@en

CRISPR-targeted genome editing ...... s: a path to clinical success?

@nl

type

label

CRISPR-targeted genome editing ...... s: a path to clinical success?

@en

CRISPR-targeted genome editing ...... s: a path to clinical success?

@nl

prefLabel

CRISPR-targeted genome editing ...... s: a path to clinical success?

@en

CRISPR-targeted genome editing ...... s: a path to clinical success?

@nl

P1433

Q37692502-EA49A3AD-30C9-4ABB-9540-9152C2470597

P1476

Q37692502-CF4939ED-B950-4A66-8D7F-8A54AD53450F

P2093

Q37692502-2179D578-59C5-4D09-A06F-720F4F71E43B

Q37692502-E09A2CC4-FC72-46C6-BA7C-2A173AB25349

P275

Q37692502-06C687F5-8C9F-41DF-8ABF-B0E0996F2D05

P2860

Q37692502-07DC3EE6-16B8-41ED-9A1B-C87380CDF386

Q37692502-099E0F4E-38BE-4846-BDE9-21DFED8F7A10

Q37692502-101AC15D-1ADE-4778-B9A1-2ABEED8F20B8

Q37692502-195D9B2B-BB60-4AAD-9382-02E972437423

Q37692502-1E4D947C-6B31-4A55-B074-9737957C3C7E

Q37692502-1EB92732-BCD7-4132-BB1F-090B37767234

Q37692502-29269413-C1B9-4E58-905F-E787279902E0

Q37692502-346E0D32-2C6F-4238-B692-0A2F3A3B6621

Q37692502-379EC014-FF69-40FD-A879-54FD7AA07DA5

Q37692502-38AE0ED0-41C5-479F-B7BB-6914A6068229

P2888

Q37692502-5BEDCC4F-542E-401E-B754-60FB4B36F66B

P304

Q37692502-7FBF96CA-FD6A-4E28-8F83-BC43CCE77F80

P31

Q37692502-EDBAED64-B99C-492B-AE57-FECB213E8B76

Q37692502-FB433F8D-1773-41DE-AFA5-2861D984EEC8

P356

Q37692502-EFC20600-A817-4F78-A9B3-A03A3476CCF5

P433

Q37692502-65883F84-A557-42DA-B43C-48DA1833163C

P478

Q37692502-9317AC51-B259-4CAB-8740-D9A30492D793

P50

Q37692502-0E529114-60FB-45AC-A380-A2DFDA3DC619

Q37692502-9DF86D8F-9B39-45C4-AD3E-4D368ECEDB59

Q37692502-D6411389-8262-4156-AEE6-F552B622511F

Q37692502-F2A18852-67E7-40A8-B854-78AF68C6ACC2

P5008

Q37692502-91F90BF9-F593-4384-9E66-973B71F808C7

P577

Q37692502-9EE0B0DD-5E62-4564-9D40-83CF2C18FE6B

P6179

Q37692502-21D21310-A670-4A2B-AD5D-2B79C31C9F26

P698

Q37692502-E129C033-7248-4F82-B182-A69133D369BA

P921

Q37692502-5187C63D-9CC9-4CAB-8456-28906EF767DD

Q37692502-7D252129-1028-4207-AB94-A9415349202B

Q37692502-8D4C8EF0-95E7-4725-B593-1C96EBB34AAD

Q37692502-E6F13961-3EDA-4180-8282-AE3865711305

P932

Q37692502-EDD57231-12FE-439F-B21C-89EB052CDF2F

P356

S13287-017-0511-8

P1433

Stem Cell Research & Therapy

P1476

CRISPR-targeted genome editing ...... s: a path to clinical success?

@en

P2093

Ann Margaret Simpson

http://www.w3.org/2001/XMLSchema#string

Najah Therese Nassif

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

Mesenchymal stem cells migration homing and tracking

Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models

Development and applications of CRISPR-Cas9 for genome engineering.

Generation of functional human pancreatic β cells in vitro

Adipose-derived stem cells for regenerative medicine

Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1.

Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro.

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex.

P2888

s13287-017-0511-8

P304

62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13287-017-0511-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Raymond J Steptoe

Rosetta Martiniello-Wilks

P5008

P577

2017-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084252430

http://www.w3.org/2001/XMLSchema#string

P698

28279194

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

regulation of gene expression

biomedical investigative technique

P932

5345178

http://www.w3.org/2001/XMLSchema#string